These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11845598)
1. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia. Kotze MJ S Afr Med J; 2001 Dec; 91(12):1042. PubMed ID: 11845598 [No Abstract] [Full Text] [Related]
2. Clinical versus molecular diagnosis of heterozygous familial hypercholesterolaemia in the diverse South African population. Vergotine J; Thiart R; Kotze MJ S Afr Med J; 2001 Dec; 91(12):1053-9. PubMed ID: 11845603 [TBL] [Abstract][Full Text] [Related]
3. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954 [TBL] [Abstract][Full Text] [Related]
4. [Application of gene technology in the diagnosis of familial hypercholesterolemia]. Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece. Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044 [TBL] [Abstract][Full Text] [Related]
6. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. Minhas R; Humphries SE; Qureshi N; Neil HA; Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470 [No Abstract] [Full Text] [Related]
7. Prenatal diagnosis of familial hypercholesterolemia: importance of DNA analysis in the high-risk South African population. Vergotine J; Thiart R; Langenhoven E; Hillermann R; De Jong G; Kotze MJ Genet Couns; 2001; 12(2):121-7. PubMed ID: 11491306 [TBL] [Abstract][Full Text] [Related]
8. People at risk of familial hypercholesterolaemia should have DNA test, says NICE. BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374 [No Abstract] [Full Text] [Related]
10. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance. Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228 [TBL] [Abstract][Full Text] [Related]
11. Manifestations of familial hypercholesterolaemia. Gillett MJ; Burnett JR Intern Med J; 2005 Jan; 35(1):63-4. PubMed ID: 15667473 [No Abstract] [Full Text] [Related]
12. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658 [TBL] [Abstract][Full Text] [Related]
13. Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive. Kastelein JJ BMJ; 2000 Dec; 321(7275):1483-4. PubMed ID: 11118161 [No Abstract] [Full Text] [Related]
14. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia. Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF; Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837 [No Abstract] [Full Text] [Related]